Stroke/Vascular Neurology News

A study published in Neurology found that the risk of rupture in familial unruptured intracranial aneurysms, or UIAs, is higher than in sporadic UIAs.

In a recent population-based cohort study, researchers observed an increased risk for cerebral venous sinus thrombosis after administration of the Johnson & Johnson COVID-19 vaccine.

The FDA has classified Zimmer Biomet’s recall of a robotic platform for neurosurgeons as Class 1, the most serious type of recall.

Xarelto was superior to aspirin for lowering the risk for recurrent stroke or systemic embolism among individuals with left ventricular dysfunction, according to results of a post hoc exploratory analysis of a randomized clinical trial.

In this video from the Annual Meeting of the American Neurological Association, Jennifer Frontera, MD, discussed a plenary session, "Hypoxic/Anoxic Injury in the CNS."

Use of a transitions of care clinic may reduce 30-day stroke readmissions, according to findings presented at the American Neurological Association annual meeting.

Women were found to be underrepresented in clinical trials looking at stroke when compared to the prevalence of stroke among women in the disease population, according to study results published in Neurology.

For patients with acute ischemic stroke due to large vessel occlusion, contact aspiration and stent retriever therapy did not improve the rate of near-total or total reperfusion compared with stent retriever alone, concluded new results.

Interventions that targeted vascular risk factors in a real-world setting did not appear to reduce dementia incidence in old age, according to study results in a research letter published in JAMA Neurology.

More than 50% of individuals with thrombosis and thrombocytopenia syndrome linked to COVID-19 vector-based vaccine administration presented with cerebral venous sinus thrombosis, according to a study.